Tyra Biosciences
TYRA
TYRA
46 hedge funds and large institutions have $387M invested in Tyra Biosciences in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
22% less capital invested
Capital invested by funds: $494M → $387M (-$108M)
37% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 19
Holders
46
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$6.84M | |
| 2 | +$6.65M | |
| 3 | +$6.41M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$1.19M |
| 5 |
JPMorgan Chase & Co
New York
|
+$791K |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$3.62M | |
| 3 | -$2.75M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.36M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.91M |